Todd Matthew Morgan MD

Assistant Professor, Urology
Specialties: 
Urology
Clinical Interests:
Prostate Cancer, Bladder Cancer, Kidney Cancer, Testis Cancer, Robotic Surgery

Video profile

Locations

U of M Urology

Cancer Center Floor B1 Reception C
1500 E Medical Center Dr SPC 5913
Ann Arbor
MI
48109
Phone:
734-647-8903
Fax:
734-647-8860

Credentials

Medical School or Training

  • Harvard Medical School, 2003

Residency

  • University of Washington Medical Center, Surgery General, WA, 2004

  • University of Washington Medical Center, Urology, WA, 2009

Fellowship

  • Urologic Oncology, Vanderbilt University Medical Center, 2011

Professional Organizations

  • American Urological Association

  • Society of Urologic Oncology

  • American Association of Cancer Research

Board Certification

  • Urology

Research

Dr. Morgan's laboratory focuses on the identification and treatment of early disseminated tumor cells in men with prostate cancer thought to have localized disease. Additional areas of research include identifying and understanding molecular markers of indolent vs. aggressive disease in prostate and kidney cancer.

View Research Profile at Michigan Expertshttp://www.experts.umich.edu//expert.asp?n=Todd+Morgan&u_id=5314

Biography

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Previously at Vanderbilt University, he joined the faculty at the University of Michigan in 2012. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology and subsequent faculty appointment at Vanderbilt. Dr. Morgan's research focuses on understanding the early spread of prostate cancer cells, with the aim of identifying those patients with the most aggressive tumors and developing appropriate therapeutic strategies for these individuals.